Select Page
Home » Expert Content » Development & Bioavailability » Streamline Early Drug Development

How Do I Streamline Early Drug Development while Planning for the Future?

Summary: Because of the industry-wide needs for R&D efficacy, there has been an increasing emphasis on speed and cost savings to get into clinic quickly. This may lead to a gap in the focus on chemistry, manufacturing and chemistry controls (CMC) between early- and late- phase development. Companies should create a development strategy that bridges such potential gaps earlier in the process to make the transition smoother.

Download the Article